Upcoming Clinical Webinar

Magnesium citrate supplementation in obese, untreated or newly diagnosed prediabetic subjects without hypomagnesemia: a 12-week, placebo-controlled, double-blinded pilot trial
Date & Time: May 19, 2020 9am CET Available On Demand

Dr. Tanja Werner explains direct and indirect effects of magnesium on cellular mechanisms. In addition, she reviews existing research on the correlation between magnesium intake and risk of type II diabetes. Current status of research relating to correlation of magnesium supplementation and course of disease in pre-diabetic and diabetic patients will be presented. Dr. Werner will also present her recent pilot study results examining magnesium supplementation in untreated pre-diabetic, hypertensive subjects without hypomagnesemia.

Speaker
Dr. Tanja Werner
Leitung Medizin und Wissenschaft
Protina Pharmazeutische GmbH


Learning objectives
  • Get an overview on prevalence of diabetes and development
  • Understand direct and indirect effects of magnesium on cellular mechanisms
  • Learn about the correlation between magnesium intake and risk of type II diabetes
  • Gain insight into the relation between magnesium supplementation and course of disease in pre-diabetic and diabetic patients

 

 

 

 

 

WATCH NOW»